Regarding IGF2BP2, it was upregulated in HCC patients compared to healthy controls, and IGF2BP2 expression was positively associated with decreased tumor differentiation and increased size, metastasis and portal vein infiltration in HCC (95). The gene discussed is IGF2BP2; the disease is hepatocellular carcinoma.